• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ETON

ETON

Eton Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD27.61

+0.21 (+0.77%)

Rating:C-

Company Profile

CEO

Sean E. Brynjelsen

IPO Date

2018-11-13

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$26.99

Prev. Close

$27.40

Day Low

$26.66

Day High

$27.63

52W Low

$13.09

52W High

$35.66

Market Cap

$0.76B

Volume

0.33M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

37.6%

Avg Negative

11.2%

Avg Neutral

51.4%

News Feed

Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/16/2021·↓ negative

Eton Pharmaceuticals Reports Second Quarter Financial Results

GlobeNewsWire·8/16/2021·↑ positive

Why Is Eton Pharmaceuticals (ETON) Stock Plunging On Monday?

Benzinga·8/9/2021·↓ negative

Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Zacks Investment Research·8/4/2021·↑ positive

Eton Pharmaceuticals Buys US, Canadian Rights To Zeneo Hydrocortisone Autoinjector

Benzinga·6/16/2021·↑ positive

CROSSJECT : US & Canada licensing agreement with Eton Pharmaceuticals for Crossject's ZENEO® Hydrocortisone

GlobeNewsWire·6/16/2021·↓ negative

Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO® Hydrocortisone Autoinjector

GlobeNewsWire·6/15/2021·↑ positive

Eton Pharma Stock Is Trading Higher After FDA Approval For Rezipres

Benzinga·6/15/2021·↑ positive

Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)

GlobeNewsWire·6/15/2021·↑ positive

Eton Pharmaceuticals, Inc. (ETON) Stock Jumps 5.4%: Will It Continue to Soar?

Zacks Investment Research·6/4/2021·↑ positive